185 related articles for article (PubMed ID: 31578365)
1. A robust bacterial assay for high-throughput screening of human 4-hydroxyphenylpyruvate dioxygenase inhibitors.
Neuckermans J; Mertens A; De Win D; Schwaneberg U; De Kock J
Sci Rep; 2019 Oct; 9(1):14145. PubMed ID: 31578365
[TBL] [Abstract][Full Text] [Related]
2. High-throughput quantification of ochronotic pigment formation in
Neuckermans J; Lequeue S; Mertens A; Branson S; Schwaneberg U; De Kock J
MethodsX; 2021; 8():101181. PubMed ID: 33365261
[TBL] [Abstract][Full Text] [Related]
3. Novel bacterial bioassay for a high-throughput screening of 4-hydroxyphenylpyruvate dioxygenase inhibitors.
Rocaboy-Faquet E; Noguer T; Romdhane S; Bertrand C; Dayan FE; Barthelmebs L
Appl Microbiol Biotechnol; 2014 Aug; 98(16):7243-52. PubMed ID: 24816780
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of para-Hydroxyphenylpyruvate Dioxygenase by Analogues of the Herbicide Nitisinone As a Strategy to Decrease Homogentisic Acid Levels, the Causative Agent of Alkaptonuria.
Laschi M; Bernardini G; Dreassi E; Millucci L; Geminiani M; Braconi D; Marzocchi B; Botta M; Manetti F; Santucci A
ChemMedChem; 2016 Apr; 11(7):674-8. PubMed ID: 26947423
[TBL] [Abstract][Full Text] [Related]
5. 4-Hydroxyphenylpyruvate Dioxygenase and Its Inhibition in Plants and Animals: Small Molecules as Herbicides and Agents for the Treatment of Human Inherited Diseases.
Santucci A; Bernardini G; Braconi D; Petricci E; Manetti F
J Med Chem; 2017 May; 60(10):4101-4125. PubMed ID: 28128559
[TBL] [Abstract][Full Text] [Related]
6. 4-Hydroxyphenylpyruvate dioxygenase.
Moran GR
Arch Biochem Biophys; 2005 Jan; 433(1):117-28. PubMed ID: 15581571
[TBL] [Abstract][Full Text] [Related]
7. A robust bacterial high-throughput screening system to evaluate single nucleotide polymorphisms of human homogentisate 1,2-dioxygenase in the context of alkaptonuria.
Lequeue S; Neuckermans J; Nulmans I; Schwaneberg U; Vanhaecke T; De Kock J
Sci Rep; 2022 Nov; 12(1):19452. PubMed ID: 36376482
[TBL] [Abstract][Full Text] [Related]
8. Pyrazolone-quinazolone hybrids: a novel class of human 4-hydroxyphenylpyruvate dioxygenase inhibitors.
Xu YL; Lin HY; Cao RJ; Ming ZZ; Yang WC; Yang GF
Bioorg Med Chem; 2014 Oct; 22(19):5194-211. PubMed ID: 25182962
[TBL] [Abstract][Full Text] [Related]
9. The Inhibitory Activity of Plants from Central Argentina on p-Hydroxyphenylpyruvate Dioxygenase. Isolation and Mechanism of Inhibition of a Flavanone from Flourensia oolepis.
Chiari ME; Tosoni L; Joray MB; Diaz Napal GN; Palacios SM; Ruiz GM; Vera DM; Carpinella MC
Planta Med; 2015 Oct; 81(15):1382-91. PubMed ID: 26291655
[TBL] [Abstract][Full Text] [Related]
10. Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone.
Preston AJ; Keenan CM; Sutherland H; Wilson PJ; Wlodarski B; Taylor AM; Williams DP; Ranganath LR; Gallagher JA; Jarvis JC
Ann Rheum Dis; 2014 Jan; 73(1):284-9. PubMed ID: 23511227
[TBL] [Abstract][Full Text] [Related]
11. Hydrophobicity-oriented drug design (HODD) of new human 4-hydroxyphenylpyruvate dioxygenase inhibitors.
Ndikuryayo F; Kang WM; Wu FX; Yang WC; Yang GF
Eur J Med Chem; 2019 Mar; 166():22-31. PubMed ID: 30684868
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and bioevaluation of pyrazole-benzimidazolone hybrids as novel human 4-Hydroxyphenylpyruvate dioxygenase inhibitors.
Xu YL; Lin HY; Ruan X; Yang SG; Hao GF; Yang WC; Yang GF
Eur J Med Chem; 2015 Mar; 92():427-38. PubMed ID: 25590863
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a potent, non-triketone type inhibitor of 4-hydroxyphenylpyruvate dioxygenase.
Lin SW; Lin YL; Lin TC; Yang DY
Bioorg Med Chem Lett; 2000 Jun; 10(11):1297-8. PubMed ID: 10866404
[TBL] [Abstract][Full Text] [Related]
14. Mode of action of 4-hydroxyphenylpyruvate dioxygenase inhibition by triketone-type inhibitors.
Wu CS; Huang JL; Sun YS; Yang DY
J Med Chem; 2002 May; 45(11):2222-8. PubMed ID: 12014960
[TBL] [Abstract][Full Text] [Related]
15. Herbicidal 4-hydroxyphenylpyruvate dioxygenase inhibitors--a review of the triketone chemistry story from a Syngenta perspective.
Beaudegnies R; Edmunds AJ; Fraser TE; Hall RG; Hawkes TR; Mitchell G; Schaetzer J; Wendeborn S; Wibley J
Bioorg Med Chem; 2009 Jun; 17(12):4134-52. PubMed ID: 19349184
[TBL] [Abstract][Full Text] [Related]
16. Predicting tyrosinaemia: a mathematical model of 4-hydroxyphenylpyruvate dioxygenase inhibition by nitisinone in rats.
Ward JP; Dunster JL; Derks G; Mistry P; Salazar JD
Math Med Biol; 2017 Sep; 34(3):335-390. PubMed ID: 27305933
[TBL] [Abstract][Full Text] [Related]
17. Interference of hydroxyphenylpyruvic acid, hydroxyphenyllactic acid and tyrosine on routine serum and urine clinical chemistry assays; implications for biochemical monitoring of patients with alkaptonuria treated with nitisinone.
Curtis SL; Norman BP; Milan AM; Gallagher JA; Olsson B; Ranganath LR; Roberts NB
Clin Biochem; 2019 Sep; 71():24-30. PubMed ID: 31228435
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Herbicidal Activity of Triketone-Quinoline Hybrids as Novel 4-Hydroxyphenylpyruvate Dioxygenase Inhibitors.
Wang DW; Lin HY; Cao RJ; Chen T; Wu FX; Hao GF; Chen Q; Yang WC; Yang GF
J Agric Food Chem; 2015 Jun; 63(23):5587-96. PubMed ID: 26006257
[TBL] [Abstract][Full Text] [Related]
19. 4-Hydroxyphenylpyruvate dioxygenase inhibitors in combination with safeners: solutions for modern and sustainable agriculture.
Ahrens H; Lange G; Müller T; Rosinger C; Willms L; van Almsick A
Angew Chem Int Ed Engl; 2013 Sep; 52(36):9388-98. PubMed ID: 23893910
[TBL] [Abstract][Full Text] [Related]
20. Identification of a novel 4-hydroxyphenylpyruvate dioxygenase from the soil metagenome.
Lee CM; Yeo YS; Lee JH; Kim SJ; Kim JB; Han NS; Koo BS; Yoon SH
Biochem Biophys Res Commun; 2008 May; 370(2):322-6. PubMed ID: 18381065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
